HNGE Hinge Health, Inc.
Healthcare$55.25+0.24%ClosedMarket Cap: $4.28B
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
13.94
P/S
6.61
EV/EBITDA
-7.81
DCF Value
$-163.67
FCF Yield
4.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
81.0%
Operating Margin
-81.6%
Net Margin
-95.1%
ROE
-167.0%
ROA
-84.3%
ROIC
-165.6%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $182.3M | 84.6% | $32.1M | $35.1M | $— | — |
| Q4 null | $170.7M | 84.4% | $27.3M | $32.1M | $— | — |
| FY null | $587.9M | 79.8% | $-546.4M | $-528.3M | $— | — |
| Q3 null | $154.2M | 81.9% | $-6.1M | $-1.8M | $— | — |
| Q2 null | $139.1M | 70.9% | $-580.7M | $-679.8M | $— | — |
| Q1 null | $123.8M | 80.9% | $13.1M | $121.3M | $— | — |
| Q4 null | $117.3M | 81.9% | $20.9M | $27.1M | $— | — |
| FY null | $390.4M | 77.0% | $-31.9M | $-11.9M | $— | — |
| Q3 null | $100.6M | 78.8% | $-3.8M | $341.0K | $— | — |
| Q2 null | $89.8M | 74.2% | $-17.6M | $-12.9M | $— | — |
| Q1 null | $82.7M | 70.1% | $-30.4M | $-26.5M | $— | — |
| Q4 2023 | $81.5M | 71.7% | $-30.5M | $-24.1M | $-0.31 | — |